1N9.F NeutriSci International Inc

Healthcare Pharmaceuticals Frankfurt Exchange
0.0034 EUR
Close of Jul 16, 2024
0.0005 0.0005
Market cap
EUR 600K
P/E
-
P/B
15.21x
ROE
-
Dividend yield
-
Fundamental score
-

Is 1N9.F undervalued?

Graham number

The Graham number of NeutriSci International Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NeutriSci International Inc fundamental analysis

No fundamental analysis for NeutriSci International Inc yet.

NeutriSci International Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NeutriSci International Inc

NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Full company profile